Heart involvement in systemic lupus erythematosus and antiphospholipid syndrome

被引:0
作者
Costedoat-Chalumeau, N. [1 ,2 ,3 ]
Le Guern, V [1 ]
Morel, N. [1 ]
机构
[1] Hop Cochin, AP HP, Serv Med Interne, Ctr Reference Malad Auto Immunes & Syst Rare Ile, Paris, France
[2] Univ Paris, Paris, France
[3] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75004 Paris, France
来源
REVUE DE MEDECINE INTERNE | 2021年 / 42卷 / 10期
关键词
Heart; Pericarditis; Myocarditis; Systemic lupus erythematosus; Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome; MANIFESTATIONS; PERICARDITIS; COLCHICINE; COHORT;
D O I
10.1016/j.revmed.2021.10.324
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A220 / A222
页数:3
相关论文
共 21 条
[11]   Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis [J].
Imazio, Massimo ;
Brucato, Antonio ;
Forno, Davide ;
Ferro, Silvia ;
Belli, Riccardo ;
Trinchero, Rita ;
Adler, Yehuda .
HEART, 2012, 98 (14) :1078-1082
[12]   Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision [J].
Iqubal, Ashif ;
Iqubal, Mohammad Kashif ;
Sharma, Sumit ;
Ansari, Mohd. Asif ;
Najmi, Abul Kalam ;
Ali, Syed Mansoor ;
Ali, Javed ;
Haque, Syed Ehtaishamul .
LIFE SCIENCES, 2019, 218 :112-131
[13]   Acute lupus myrocarditis: clinical features and outcome of an oriental case series [J].
Law, WG ;
Thong, BY ;
Lian, TY ;
Kong, KO ;
Chng, HH .
LUPUS, 2005, 14 (10) :827-831
[14]   A rare cause of impaired general condition: Muscular and cardiac toxicity of antimalarials [J].
Lenfant, T. ;
Dion, J. ;
Maisonobe, T. ;
Costedoat-Chalumeau, N. .
REVUE DE MEDECINE INTERNE, 2020, 41 (05) :335-338
[15]   Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases [J].
Morel, N. ;
Bonjour, M. ;
Le Guern, V. ;
Le Jeunne, C. ;
Mouthon, L. ;
Piette, J-C ;
Costedoat-Chalumeau, N. .
LUPUS, 2015, 24 (14) :1479-1485
[16]   Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus [J].
Petri, Michelle ;
Orbai, Ana-Maria ;
Alarcon, Graciela S. ;
Gordon, Caroline ;
Merrill, Joan T. ;
Fortin, Paul R. ;
Bruce, Ian N. ;
Isenberg, David ;
Wallace, Daniel J. ;
Nived, Ola ;
Sturfelt, Gunnar ;
Ramsey-Goldman, Rosalind ;
Bae, Sang-Cheol ;
Hanly, John G. ;
Sanchez-Guerrero, Jorge ;
Clarke, Ann ;
Aranow, Cynthia ;
Manzi, Susan ;
Urowitz, Murray ;
Gladman, Dafna ;
Kalunian, Kenneth ;
Costner, Melissa ;
Werth, Victoria P. ;
Zoma, Asad ;
Bernatsky, Sasha ;
Ruiz-Irastorza, Guillermo ;
Khamashta, Munther A. ;
Jacobsen, Soren ;
Buyon, Jill P. ;
Maddison, Peter ;
Dooley, Mary Anne ;
van vollenhoven, Ronald F. ;
Ginzler, Ellen ;
Stoll, Thomas ;
Peschken, Christine ;
Jorizzo, Joseph L. ;
Callen, Jeffrey P. ;
Lim, S. Sam ;
Fessler, Barri J. ;
Inanc, Murat ;
Kamen, Diane L. ;
Rahman, Anisur ;
Steinsson, Kristjan ;
Franks, Andrew G., Jr. ;
Sigler, Lisa ;
Hameed, Suhail ;
Fang, Hong ;
Ngoc Pham ;
Brey, Robin ;
Weisman, Michael H. .
ARTHRITIS AND RHEUMATISM, 2012, 64 (08) :2677-2686
[17]   Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry [J].
Rodriguez-Pinto, Ignasi ;
Moitinho, Marta ;
Santacreu, Irene ;
Shoenfeld, Yehuda ;
Erkan, Doruk ;
Espinosa, Gerard ;
Cervera, Ricard .
AUTOIMMUNITY REVIEWS, 2016, 15 (12) :1120-1124
[18]  
Ryu S, 2017, LUPUS SCI MED, V4, DOI 10.1136/lupus-2017-000221
[19]   Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban [J].
Stammler, Romain ;
Legendre, Paul ;
Cacoub, Patrice ;
Blanche, Philippe ;
Piette, Jean-Charles ;
Costedoat-Chalumeau, Nathalie .
LUPUS, 2020, 29 (07) :787-790
[20]   Atherosclerosis in Systemic Lupus Erythematosus [J].
Stojan, George ;
Petri, Michelle .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (03) :255-262